Metabolomics reveals biomarkers of opioid use disorder

Opioid use disorder (OUD) is diagnosed using the qualitative criteria defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Diagnostic biomarkers for OUD do not currently exist. Our study focused on developing objective biological markers to differentiate chron...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghanbari, Reza, Li, Yuanyuan, Pathmasiri, Wimal, McRitchie, Susan, Etemadi, Arash, Pollock, Jonathan D., Poustchi, Hossein, Rahimi-Movaghar, Afarin, Amin-Esmaeili, Masoumeh, Roshandel, Gholamreza, Shayanrad, Amaneh, Abaei, Behrouz, Malekzadeh, Reza, Sumner, Susan C. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862627/
https://www.ncbi.nlm.nih.gov/pubmed/33542199
http://dx.doi.org/10.1038/s41398-021-01228-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862627/
https://www.ncbi.nlm.nih.gov/pubmed/33542199
http://dx.doi.org/10.1038/s41398-021-01228-7

Ejemplares similares